Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Myriad Genetics to Present at Citis 4th Annual Biotech Day on April 2009
Myriad, 04/16/09
Myriad Genetics, Inc. announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at Citi's 4th Annual Biotech Day, at 3:20 p.m. on April 1, at the 338 Greenwich Street Conference Center in New York, NY.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
PR distribution service for the biotech industry
b3c newswire, 12/07/09
Safety First in Biotech Development
BioPharm, 12/03/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor